NCT05341947 2025-10-22
Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
Cedars-Sinai Medical Center
Phase 1 Withdrawn
Clinical Trials
46 trialsNCT06501911 2025-07-22
A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
University of Nebraska
Phase 1 Withdrawn
NCT06463184 2024-12-04
Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT04521946 2024-10-26
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT03990597 2024-10-09
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT05773664 2024-09-19
Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
City of Hope Medical Center
Phase 1 Withdrawn
NCT05082493 2024-06-06
A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
WPD Pharmaceuticals Sp. z o.o.
Phase 1 Withdrawn
NCT03935269 2024-03-20
CERESET
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT05672082 2024-02-08
INFLAGLI
Center Eugene Marquis
Phase NA Withdrawn
NCT05373381 2024-02-02
The KetoGlioma (Ketogenic Glioma) Study
Tufts Medical Center
Phase NA Withdrawn
NCT05054400 2023-09-01
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT04741984 2023-05-15
DEMAND
Duke University
Phase 1 Withdrawn
NCT03956706 2023-03-15
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Northwell Health
Phase NA Withdrawn
NCT03649464 2022-10-07
Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
Oblato, Inc.
Phase 1/2 Withdrawn
NCT05061251 2022-01-11
Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04220892 2020-07-31
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Saint John's Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT02575261 2020-07-16
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Withdrawn
NCT04406610 2020-07-16
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Withdrawn
NCT02713984 2020-03-19
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
Southwest Hospital, China
Phase 1/2 Withdrawn
NCT02754362 2020-01-13
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
NYU Langone Health
Phase 2 Withdrawn
NCT01117155 2019-12-12
A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT00977795 2019-09-10
A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors
Endeavor Health
Phase 1/2 Withdrawn
NCT02689336 2019-09-09
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
Phase 2 Withdrawn
NCT01212237 2019-07-29
Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Weill Medical College of Cornell University
Withdrawn
NCT02540135 2018-07-20
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
University of Colorado, Denver
Phase NA Withdrawn
NCT03275558 2018-07-19
Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
Center Trials & Treatment
Phase 1 Withdrawn
NCT02977689 2017-12-20
Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
NYU Langone Health
Phase 2 Withdrawn
NCT02987010 2017-10-11
Phase 2 Study of IDH305 in Low Grade Gliomas
University of Texas Southwestern Medical Center
Phase 2 Withdrawn
NCT02194452 2017-04-28
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
University of Iowa
Phase NA Withdrawn
NCT02976441 2017-02-20
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
Washington University School of Medicine
Phase EARLY_PHASE1 Withdrawn
NCT02165995 2016-12-29
Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT01961934 2016-09-28
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Phoenix Molecular Imaging
Phase 2/3 Withdrawn
NCT01445691 2016-05-17
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
Icahn School of Medicine at Mount Sinai
Phase 2 Withdrawn
NCT01249105 2016-03-10
MK-2206 for Recurrent Malignant Glioma
Dana-Farber Cancer Institute
Phase 2 Withdrawn
NCT01861990 2015-05-22
Valproic Acid in Childhood Progressive Brain Tumors
Medical University of South Carolina
Phase 1 Withdrawn
NCT01711580 2015-05-12
Re-irradiation of High Grade Gliomas: a Quality of Life Study
Maastricht Radiation Oncology
Withdrawn
NCT00378235 2014-11-13
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
INSYS Therapeutics Inc
Phase 1/2 Withdrawn
NCT01952886 2014-09-22
Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients
Duke University
Phase 2 Withdrawn
NCT01778088 2014-02-25
Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma
Cellectar Biosciences, Inc.
Phase 2 Withdrawn
NCT00797940 2012-12-03
CLARITY-1
Protox Inc.
Phase 2 Withdrawn
NCT00005083 2012-10-04
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00005790 2012-06-11
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Northwestern University
Phase NA Withdrawn
NCT00985036 2012-04-24
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Marquette General Health System
Withdrawn
NCT00003564 2012-02-22
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
M.D. Anderson Cancer Center
Phase 3 Withdrawn
NCT00469534 2011-09-22
Minimized Time to Beam in Patients With High Grade Gliomas
AHS Cancer Control Alberta
Phase NA Withdrawn
NCT00243490 2010-01-12
Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
National Taiwan University Hospital
Phase 2 Withdrawn